Study on Indomethacin-responsive Headaches

N/AUnknownNCT03967483

Anne Ducros100 enrolled

Overview

Description of modalities concerning the patient care of headaches sensible to indometacine.

Description of clinical profile, treatment of crisis and background treatment

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Headache, Migraine

Interventions

IndometacinDRUG

patient who are taken indomatacin for headaches and migraine

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patient with a diagnosis of migraine with or without aura, or trigemino-autosomic headaches or other primary headaches * patient who are taking indometacine * patient with written consent form Exclusion Criteria: * patient under 18 years * pregnant woman or breastfeeding patient * patient who refuses to participate

Outcomes

Primary Outcomes

Description of headaches sensible to indometacine

Description of the clinical cases with headaches sensible to indometacine according to the type of headaches.

Time frame: 24 monthes

Central Contacts

Anne DONNET

CONTACT

0491384340 Anne.DONNET@ap-hm.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.